Heart Valve Prosthesis

• 

  Subject Areas on Research

  • 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. 
  • 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 
  • 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 
  • 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 
  • 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 
  • 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease. 
  • 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease. 
  • 3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial. 
  • A clinical comparison of mitral valve repair versus valve replacement in ischemic mitral regurgitation. 
  • A critical review of hemodynamic changes and left ventricular remodeling after surgical aortic valve replacement and percutaneous aortic valve replacement. 
  • A pathoanatomic approach to secondary functional mitral regurgitation: Evaluating the evidence. 
  • A preliminary study of the effects of cardiac procedures on cognitive performance. 
  • A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial. 
  • Accelerated TPA for treatment of prosthetic valve thrombosis. 
  • Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. 
  • Acute lower extremity ischemia after cardiac surgery. 
  • Acute thrombosis of a composite ascending aortic conduit containing a Bjork-Shiley valve during pregnancy: successful emergency cesarean section and operative repair. 
  • An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481--The Home INR Study (THINRS). 
  • An evaluation of prosthetic aortic valves using transesophageal echocardiography: the double-envelope technique. 
  • An evaluation of the Duke criteria in 25 pathologically confirmed cases of prosthetic valve endocarditis. 
  • Anisotropic poly(ethylene glycol)/polycaprolactone hydrogel-fiber composites for heart valve tissue engineering. 
  • Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement. 
  • Anticoagulation for coexisting bioprosthetic aortic valve thrombosis and anticoagulant-related bleeding: "A double edge sword". 
  • Anticoagulation: choosing the optimal anticoagulant. 
  • Anticoagulation: indications and risk classification schemes. 
  • Anticoagulation: managing adverse events in patients receiving anticoagulation and perioperative care. 
  • Anticoagulation: monitoring of patients receiving anticoagulation. 
  • Antimicrobial activity of prosthetic heart valve sewing cuffs coated with minocycline and rifampin. 
  • Antithrombotic Regimens in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement: Trials Evaluating Patient-Centered Outcomes Needed. 
  • Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician. 
  • Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). 
  • Aortic Prosthetic Valve Endocarditis: Analysis of The Society of Thoracic Surgeons Database. 
  • Aortic Valve Replacement and Patient-Centered Implementation: To Boldly Go Where No Device Has Gone Before. 
  • Aortic valve replacement in adults after balloon aortic valvuloplasty. 
  • Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model. 
  • Aspergillus clavatus endocarditis involving a normal aortic valve following coronary artery surgery. 
  • Assessing the Utility of Transcatheter Aortic Valve Replacement. 
  • Assessment of Paravalvular Leak After Transcatheter Aortic Valve Replacement: Transesophageal Echocardiography Compared With Transthoracic Echocardiography. 
  • Assessment of left ventricular functional preservation during isolated cardiac valve operations. 
  • Association Between Transcatheter Aortic Valve Replacement and Early Postprocedural Stroke. 
  • Association between indices of prosthesis internal orifice size and operative mortality after isolated aortic valve replacement. 
  • Association of Volume and Outcomes in 234 556 Patients Undergoing Surgical Aortic Valve Replacement. 
  • Asymptomatic Severe Aortic Valve Stenosis-When to Intervene: a Review of the Literature, Current Trials, and Guidelines. 
  • Bacterial endocarditis caused by Oerskovia turbata. 
  • Balloon Post-Dilation Following Implantation of a Self-Expanding Transcatheter Aortic Valve Bioprosthesis. 
  • Balloon aortic valvuloplasty. 
  • Benchmarking Outcomes: Reoperation for Aortic Valve Patient-Prosthesis Mismatch. 
  • Branch Pulmonary Artery Valve Implantation Reduces Pulmonary Regurgitation and Improves Right Ventricular Size/Function in Patients With Large Right Ventricular Outflow Tracts. 
  • CT-Defined Prosthesis-Patient Mismatch Downgrades Frequency and Severity, and Demonstrates No Association With Adverse Outcomes After Transcatheter Aortic Valve Replacement. 
  • Calcific valvular aortic stenosis with and without mitral anular calcium. 
  • Can balloon aortic valvuloplasty help determine appropriate transcatheter aortic valve size? 
  • Candida endocarditis: contemporary cases from the International Collaboration of Infectious Endocarditis Merged Database (ICE-mD). 
  • Characteristics and clinical outcomes in patients with prior chest radiation undergoing TAVR: Observations from PARTNER-2. 
  • Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. 
  • Clinical Characteristics, Procedural Factors, and Outcomes of Percutaneous Coronary Intervention in Patients With Mechanical and Bioprosthetic Heart Valves. 
  • Clinical Valve Thrombosis After Valve-in-Valve Transcatheter Aortic Valve Replacement. 
  • Clinical characteristics and outcome of aortic endocarditis with periannular abscess in the International Collaboration on Endocarditis Merged Database. 
  • Clinical comparison of St. Jude and porcine aortic valve prostheses. 
  • Clinical comparison of St. Jude and porcine mitral valve prostheses. 
  • Clinical correlates of atrial tachyarrhythmias after valve replacement for aortic stenosis. 
  • Coagulase-negative staphylococcal prosthetic valve endocarditis--a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study. 
  • Commentary: Biologic versus mechanical valves: Wandering in the dark. 
  • Commentary: Structural abnormalities after Freestyle full aortic root replacement: Time to accept the facts. 
  • Community-acquired prosthetic valve endocarditis due to methicillin-resistant Staphylococcus aureus. 
  • Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement. 
  • Comparison of balloon valvuloplasty with operative treatment for mitral stenosis. 
  • Comparison of survival after mitral valve replacement with biologic and mechanical valves in 1139 patients. 
  • Complete heart block complicating retrograde left ventricular catheterization: case report and review. 
  • Comprehensive Echocardiographic Assessment of Normal Transcatheter Valve Function. 
  • Computed Tomography-Based Oversizing Degrees and Incidence of Paravalvular Regurgitation of a New Generation Transcatheter Heart Valve. 
  • Congenital Pulmonic Valve Dysfunction Treated With SAPIEN 3 Transcatheter Heart Valve (from the COMPASSION S3 Trial). 
  • Contemporary clinical profile and outcome of prosthetic valve endocarditis. 
  • Corynebacterium endocarditis of a percutaneously placed transcatheter pulmonary valve. 
  • Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial. 
  • Current management of mitral valve incompetence associated with coronary artery disease. 
  • Current prognosis of ischemic mitral regurgitation. Implications for future management. 
  • Dabigatran versus warfarin in patients with mechanical heart valves. 
  • Depression in male and female patients undergoing cardiac surgery. 
  • Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve). 
  • Determinants of 15-year outcome with 1,119 standard Carpentier-Edwards porcine valves. 
  • Determinants of reoperation after 960 valve replacements with Carpentier-Edwards prostheses. 
  • Development and evaluation of a pliable biological valved conduit. Part I: Preparation, biochemical properties, and histological findings. 
  • Does pregnancy affect the durability of valvular bioprostheses? 
  • Doppler Velocity Index Outcomes Following Surgical or Transcatheter Aortic Valve Replacement in the PARTNER Trials. 
  • Doppler-detected valve movement in aortic stenosis: a predictor of adverse outcome. 
  • Dynamic Left Ventricular Outflow Obstruction and Systolic Anterior Motion of the Mitral Valve Complicating Surgical Aortic Valve Replacement. 
  • Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study. 
  • Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. 
  • Early changes in left ventricular size and function after correction of left ventricular volume overload. 
  • Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations. 
  • Early surgery in patients with infective endocarditis: a propensity score analysis. 
  • Echo rounds: Intraoperative delineation of mitral annuloplasty dehiscence using three-dimensional transesophageal echocardiography. 
  • Echocardiographic evaluation of tricuspid valve endocarditis: an M mode and two dimensional study. 
  • Echocardiographic imaging of procedural complications during balloon-expandable transcatheter aortic valve replacement. 
  • Echocardiography in Clinical Trials for TAVR: Getting to the Core of the Matter. 
  • Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement: A Randomized Clinical Trial. 
  • Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial. 
  • Effect of home testing of international normalized ratio on clinical events. 
  • Effects of standard mitral valve replacement on left ventricular function. 
  • Effects of valve replacement on ventricular mechanics in mitral regurgitation and aortic stenosis. 
  • Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial. 
  • Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): a weighted meta-analysis of 9,251 patients from 46 studies. 
  • Enterococcal prosthetic valve infective endocarditis: report of 45 episodes from the International Collaboration on Endocarditis-merged database. 
  • Evaluation of suture techniques for mitral valve replacement. 
  • Experimental mitral regurgitation. Physiological effects of correction on left ventricular dynamics. 
  • False aneurysm of the aortic root: mimic of malignancy, mediator of myocardial ischemia. 
  • Fate of the autologous tri-cusp-valved pericardial conduit in the right ventricular outflow tract of growing pigs. 
  • Ferumoxtyol-enhanced MR Angiography for Transcatheter Aortic Valve Replacement Planning in Patients with Renal Failure. 
  • Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement. 
  • Fluoroscopic characterization of surgical bioprosthetic heart valves. 
  • Functional Tricuspid Regurgitation: Analysis of Percutaneous Transcatheter Techniques and Current Outcomes. 
  • Futility, benefit, and transcatheter aortic valve replacement. 
  • Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry. 
  • Geometric ring annuloplasty for bicuspid aortic valve repair in a child. 
  • Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis. 
  • Hemolytic anemia following insertion of Ionescu-Shiley mitral valve bioprosthesis. 
  • High incidence of late infective endocarditis in bovine jugular vein valved conduits. 
  • How Did We Get Here? Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement: A Review. 
  • Hybrid transcatheter pulmonary valve replacement with a SAPIEN S3 valve after pulmonary artery banding via left lateral thoracotomy. 
  • Imaging for Predicting and Assessing Prosthesis-Patient Mismatch After Aortic Valve Replacement. 
  • Impact of Aortic Root Anatomy and Geometry on Paravalvular Leak in Transcatheter Aortic Valve Replacement With Extremely Large Annuli Using the Edwards SAPIEN 3 Valve. 
  • Impact of Balloon Predilatation on Hemodynamics and Outcomes After Transcatheter Aortic Valve Implantation With the Self-Expanding CoreValve Prosthesis. 
  • Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices. 
  • Impact of dual energy cardiac CT for metal artefact reduction post aortic valve replacement. 
  • Impact of preoperative chronic lung disease on survival after surgical aortic valve replacement. 
  • Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A. 
  • Improved cardiac anthropomorphic phantom. 
  • Improving recovery following cardiac surgery: a randomized clinical trial. 
  • In vitro color flow, pulsed and continuous wave Doppler ultrasound masking of flow by prosthetic valves. 
  • In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. 
  • In vitro ultrasonic imaging of flow through prosthetic heart valves. 
  • In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. 
  • In-hospital and long-term outcome after porcine tricuspid valve replacement. 
  • Incidence and Clinical Significance of Worsening Tricuspid Regurgitation Following Surgical or Transcatheter Aortic Valve Replacement: Analysis From the PARTNER IIA Trial. 
  • Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis. 
  • Incidence, Predictors, and Outcomes of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Analysis From the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry. 
  • Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. 
  • Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. 
  • Infective endocarditis. 
  • Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. 
  • Influence of hypothermic cardiopulmonary bypass on atrial natriuretic factor levels. 
  • Initial Application of a Bicuspid Aortic Annuloplasty Ring in Pediatric Cardiac Surgery. 
  • Initial Feasibility Study of a New Transcatheter Mitral Prosthesis: The First 100 Patients. 
  • Institutional Experience With Transcatheter Mitral Valve Repair and Clinical Outcomes: Insights From the TVT Registry. 
  • Integrating valve-inspired design features into poly(ethylene glycol) hydrogel scaffolds for heart valve tissue engineering. 
  • Integrative biomechanics: A paradigm for clinical applications of fundamental mechanics 
  • Intraoperative assessment of left ventricular heterogeneity. 
  • Intraprocedural Cardiac Complications of Transcatheter Aortic and Mitral Valve Interventions: "The Eyes Do Not See What the Mind Does Not Know". 
  • Invasive hemodynamic evaluation in patients with mechanical aortic valves. 
  • Invasive hemodynamic evaluation in patients with mechanical aortic valves. Catheterization and cardiovascular interventions: official journal of the society for cardiac angiography & interventions 2013. 
  • Invited Commentary. 
  • Invited Commentary. 
  • Is Transcatheter Aortic Valve Replacement Worth the Wait? 
  • Is the valve OK or not? Immediate evaluation of a replaced aortic valve. 
  • Is this a bridge too far? 
  • Ischemic mitral regurgitation. 
  • Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. 
  • Isolation and characterization of an acquired antithrombin antibody. 
  • Kicking the can down the road-For 42 years! 
  • Left Bundle Branch Block Before Transcatheter Aortic Valve Replacement. 
  • Left ventricular performance improves late after aortic valve replacement in patients with aortic stenosis and reduced ejection fraction. 
  • Letter: Discovery of paravalvular defects. 
  • Long-Term Clinical Outcomes of Silzone Era St. Jude Medical Mechanical Heart Valves. 
  • Long-Term Survival After Bovine Pericardial Versus Porcine Stented Bioprosthetic Aortic Valve Replacement: Does Valve Choice Matter? 
  • Long-term outcome after biologic versus mechanical aortic valve replacement in 841 patients. 
  • Long-term outcomes after isolated aortic valve replacement in octogenarians: a modern perspective. 
  • Long-term outcomes of aortic root replacement for endocarditis. 
  • Long-term safety and effectiveness of mechanical versus biologic aortic valve prostheses in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. 
  • Long-term survival after aortic valve replacement among high-risk elderly patients in the United States: insights from the Society of Thoracic Surgeons Adult Cardiac Surgery Database, 1991 to 2007. 
  • Long-term survival for patients with preoperative renal failure undergoing bioprosthetic or mechanical valve replacement. 
  • Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial. 
  • Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves. 
  • Lymphocyte and monocyte subset changes during cardiopulmonary bypass: effects of aging and gender. 
  • M-mode echocardiographic observations in active bacterial endocarditis limited to the aortic valve. 
  • Management Considerations in Infective Endocarditis: A Review. 
  • Management and long-term outcome of aortic dissection. 
  • Management of asymptomatic chronic aortic regurgitation with left ventricular dysfunction: a decision analysis. 
  • Mechanisms of Death in Low-Risk Patients After Transcatheter or Surgical Aortic Valve Replacement. 
  • Melody pulmonary valve bacterial endocarditis: experience in four pediatric patients and a review of the literature. 
  • Metal Artifact-Free and Dose-Efficient Computed Tomography Imaging of a Cardiac Prosthetic Valve Using Spectral Shaping of the X-ray Beam: A Case Report. 
  • Mid-Term Outcomes of Transcatheter Aortic Valve Replacement in Extremely Large Annuli With Edwards SAPIEN 3 Valve. 
  • Midline lucency following median sternotomy. 
  • Mitral valve repair for degenerative disease: a 20-year experience. 
  • Mitral valve repair or replacement in elderly people. 
  • Mitral valve replacement for isolated mitral regurgitation: analysis of clinical course and late postoperative left ventricular ejection fraction. 
  • Mortality and timing of surgery for prosthetic valve endocarditis--reply. 
  • Neisseria gonorrhoeae endocarditis on a prosthetic valve. 
  • Neurological injury after transcatheter aortic valve implantation: are the trees falling silently or is our hearing impaired? 
  • Novel approaches to clinical trials: device-related infections. 
  • One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis. 
  • One-Year Outcomes After MitraClip for Functional Mitral Regurgitation. 
  • Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs. 
  • Outcome of Flow-Gradient Patterns of Aortic Stenosis After Aortic Valve Replacement: An Analysis of the PARTNER 2 Trial and Registry. 
  • Outcomes After Transcatheter Mitral Valve Repair in Patients With Renal Disease. 
  • Outcomes and prosthesis choice for active aortic valve infective endocarditis: analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • Outcomes following transcatheter aortic valve replacement in the United States. 
  • Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). 
  • Outcomes of transcatheter aortic valve replacement for patients with severe aortic stenosis and concomitant aortic insufficiency: Insights from the TVT Registry. 
  • Paecilomyces varioti endocarditis on a prosthetic aortic valve. 
  • Pannus-related prosthetic valve dysfunction and life-threatening aortic regurgitation. 
  • Partial Heart Transplantation in Adult Cardiac Surgery. 
  • Partial and transient relief of conduit obstruction by low-pressure balloon dilation in patients with congenital heart disease. 
  • Pasteurella multocida prosthetic valve endocarditis: case report and review. 
  • Pathogenesis of fungal infection on heart valve prosthesis. 
  • Patients' Willingness to Accept Mitral Valve Procedure-Associated Risks Varies Across Severity of Heart Failure Symptoms. 
  • Patterns of anticoagulation following bioprosthetic valve implantation: observations from ANSWER. 
  • Percutaneous closure of aortic prosthetic paravalvular regurgitation with two amplatzer septal occluders. 
  • Percutaneous heart valve replacement for aortic stenosis: state of the evidence. 
  • Perioperative Management of the Gynecologic Patient on Long-term Anticoagulation. 
  • Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). 
  • Post-market surveillance to detect adverse events associated with Melody® valve implantation. 
  • Precision Medicine in TAVR: How to Select the Right Device for the Right Patient. 
  • Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. 
  • Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis. 
  • Predictors of outcome of tricuspid valve replacement in carcinoid heart disease. 
  • Preservation of aortic valve in type A aortic dissection complicated by aortic regurgitation. 
  • Prevention and Management of Thromboembolism in Pregnancy When Heparins Are Not an Option. 
  • Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database. 
  • Progress in ring array transducers for real-time 3D ultrasound guidance of cardiac interventional devices. 
  • Prospective Evaluation of TMVR for Failed Surgical Annuloplasty Rings: MITRAL Trial Valve-in-Ring Arm 1-Year Outcomes. 
  • Prospective Study of TMVR Using Balloon-Expandable Aortic Transcatheter Valves in MAC: MITRAL Trial 1-Year Outcomes. 
  • Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry. 
  • Prosthesis-Patient Mismatch in Patients Undergoing Transcatheter Aortic Valve Replacement: From the STS/ACC TVT Registry. 
  • Prosthetic mitral valve replacement: late complications after native valve preservation. 
  • Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database. 
  • Prosthetic valve thrombosis: when and how should we lyse? 
  • Pseudoaneurysm formation after medtronic freestyle porcine aortic bioprosthesis implantation: a word of caution. 
  • Pulmonary Heart Valves: Redefining Outcomes. 
  • Pulmonary homograft monocusp reconstruction of the right ventricular outflow tract: outcomes to the intermediate term. 
  • Quality of life and recovery after cardiac surgery. 
  • Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve. 
  • Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. 
  • Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial. 
  • Relationship of Annular Sizing Using Multidetector Computed Tomographic Imaging and Clinical Outcomes After Self-Expanding CoreValve Transcatheter Aortic Valve Replacement. 
  • Reoperation After Transcatheter Aortic Valve Replacement: An Analysis of the Society of Thoracic Surgeons Database. 
  • Reply: Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement. 
  • Reply: To PMID 25301369. 
  • Reply: Transcatheter Versus Surgical Aortic Valve Replacement: Unneglectable Concomitant Coronary Artery Disease. 
  • Report of neoaortic valve replacement in a ten-year-old girl after an arterial switch procedure for transposition. 
  • Resolution of severe hemolysis and paravalvular aortic regurgitation employing an Amplatzer Vascular Plug 4: the importance of detailed pre-procedural planning using CT angiography. 
  • Response by Capoulade et al to Letter Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty". 
  • Results of valve replacement with mechanical and biological prostheses in chronic renal dialysis patients. 
  • Rethinking the ross procedure in adults. 
  • Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia. 
  • Risk of intravascular cardiac device infections in patients with bacteraemia: impact on device removal. 
  • Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. 
  • Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement. 
  • Risk-adjusted survival after tissue versus mechanical aortic valve replacement: a 23-year assessment. 
  • Safety and Efficacy of Self-Expanding TAVR in Patients With Aortoventricular Angulation. 
  • Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis. 
  • Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery. 
  • Serial assessment of ventricular performance after valve replacement for aortic stenosis. 
  • Sex disparities in patients with symptomatic severe aortic stenosis. 
  • Shedding More Light on Valve Thrombosis After Transcatheter Aortic Valve Replacement. 
  • Short-term and intermediate-term outcomes of aortic root replacement with St. Jude mechanical conduits and aortic allografts. 
  • Sixteen years later and the debate for transcatheter aortic valve replacement or surgical aortic valve replacement remains controversial. 
  • Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. 
  • Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial. 
  • Subclavian/Axillary Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral. 
  • Subvalvular left ventricular pseudoaneurysm after mitral valve replacement: two-dimensional echocardiographic findings. 
  • Subvalvular thrombotic obstruction of an aortic porcine heterograft. 
  • Successful treatment of Brucella melitensis end-carditis. 
  • Successful treatment of Edwardsiella tarda prosthetic valve endocarditis in a patient with AIDS. 
  • Successful treatment of prosthetic valve endocarditis due to Flavobacterium meningosepticum. 
  • Surgical Aortic Valve Replacement for Failed TAVR Prostheses: One More Piece of the Puzzle. 
  • Surgical Aortic Valve Replacement in the Transcatheter Aortic Valve Replacement Era: Implications for the Heart Team. 
  • Surgically implanted aortic valve bioprostheses deform after implantation: insights from computed tomography. 
  • Survival prognosis and surgical management of ischemic mitral regurgitation. 
  • Ten-year experience with mitral valve replacement in the elderly. 
  • Ten-year results with the St. Jude Medical prosthesis. 
  • The "ideal" replacement heart valve. 
  • The EVEREST II Trial: design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitation. 
  • The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 Registry. 
  • The Heterogeneity of Old Age: Healthy Aging in Older Adults Undergoing TAVR. 
  • The Incidence and Consequence of Prosthesis-Patient Mismatch After Surgical Aortic Valve Replacement. 
  • The Mini Mental State Exam as a predictor of neuropsychological functioning after cardiac surgery. 
  • The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: A propensity-matched comparison. 
  • The Ross procedure: shorter hospital stay, decreased morbidity, and cost effective. 
  • The Value of Echocardiography in Unexpected Valve Disease in a Patient With Ischemic Cardiomyopathy: Less Is Not Always the Right Answer. 
  • The Value of Transesophageal Echocardiography in Transcatheter Valve Procedures: Is it Still Questionable? 
  • The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study. 
  • The impact of specific preoperative organ dysfunction in patients undergoing aortic valve replacement. 
  • The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement. 
  • The role of prolonged thrombolytic infusions and transesophageal echocardiography in thrombosed prosthetic heart valves: case report and review of the literature. 
  • The role of valve replacement in the treatment of prosthetic valve endocarditis. 
  • The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort. 
  • Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United States: Data From the Society of Thoracic Surgeons/American College of Cardiology/Transcatheter Valve Therapy Registry. 
  • Tissue engineering in the cardiovascular system: progress toward a tissue engineered heart. 
  • Transapical Approach for TAVR: Keep It in the Quiver. 
  • Transcatheter Aortic Valve Implant Depth Measurements Differ by Aortography Versus Computed Tomography. 
  • Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement. 
  • Transcatheter Aortic Valve Replacement Versus Aortic Valve Bypass: A Comparison of Outcomes and Economics. 
  • Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis and Mitral Regurgitation. 
  • Transcatheter Aortic Valve Replacement in the Era of Quality Assessment. 
  • Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. 
  • Transcatheter Valve Replacement for Right-sided Valve Disease in Congenital Heart Patients. 
  • Transcatheter aortic valve replacement for aortic bioprosthetic valve failure with cardiogenic shock. 
  • Transcatheter aortic valve replacement performed via left ventricular assist device inflow cannula. 
  • Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. 
  • Transcatheter aortic valve replacement valve durability: Good enough for young, low-risk patients? 
  • Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. 
  • Transcatheter aortic-valve replacement with a self-expanding prosthesis. 
  • Transcatheter mitral valve repair for functional mitral regurgitation: Evaluating the evidence. 
  • Transcatheter therapies have not forgotten the tricuspid valve. 
  • Treatment of mechanical aortic valve thrombosis with heparin and eptifibatide. 
  • Trends in the surgical treatment of ischemic mitral regurgitation: effects of mitral valve repair on hospital mortality. 
  • Two-dimensional echocardiographic assessment of vegetative endocarditis. 
  • Two-year outcomes after transcatheter or surgical aortic-valve replacement. 
  • Unicuspid Aortic Valve Repair Using Geometric Ring Annuloplasty. 
  • Unreliability of hemodynamic indexes of left ventricular size during cardiac surgery. 
  • Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). 
  • Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. 
  • Use of an inverted On-X mitral valve in the aortic position in a resource limited setting. 
  • Use of balloon aortic valvuloplasty to size the aortic annulus before implantation of a balloon-expandable transcatheter heart valve. 
  • Use of common antiplatelet drugs for vascular diseases. 
  • Use of silver in the prevention and treatment of infections: silver review. 
  • Using a Regent Aortic Valve in a Small Annulus Mitral Position Is a Viable Option. 
  • Valve-in-Valve Transcatheter Valve Implantation in the Nonaortic Position. 
  • Valve-in-valve in the tricuspid position for a stenosed bioprosthesis. 
  • Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. 
  • Valvular heart disease. 
  • Variation in Warfarin Use at Hospital Discharge After Isolated Bioprosthetic Mitral Valve Replacement: An Analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • Ventricular pacing can induce hemodynamically significant mitral valve regurgitation. 
  • Volume and Outcomes for Transcatheter Aortic-Valve Replacement. Reply. 
  • Walking as a Window to Risk and Resiliency. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Brennan, J. Matthew, Associate Professor of Medicine, Medicine, Cardiology
  • Curtis, Lesley H., Professor in Population Health Sciences, Medicine, General Internal Medicine
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Swaminathan, Madhav, Professor of Anesthesiology, Anesthesiology, Cardiothoracic